Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This study is a cross sectional observational study to evaluate the prevalence of HLA-B*5701
in the major French ethnotypes.
Any HIV-1 infected subject will be eligible for this study including antiretroviral therapy
(ART) naÃ-ve and experienced subjects irrespective of abacavir use, as well as subjects
previously tested for HLA-B*5701. Subjects will be approached during a standard clinic visit,
and all subjects will be consented prior to any study specific procedure. Subjects will be
asked to provide a tissue sample (cheek cells and blood sample) which will be used to assess
HLA-B*5701 status by central and local methodologies.